Treatment of Extrapapillary Retinal Hemangioblastoma Greater Than 4.5 mm in Diameter
Clinical Scenario
This protocol addresses the management of extrapapillary retinal hemangioblastoma (RH) with a diameter exceeding 4.5 mm. This subgroup represents a particularly difficult treatment challenge: as tumor size increases beyond this threshold, treatment success rates decrease and procedural risks rise correspondingly.
Tumor Diameter > 4.5 mm
Specific Situation
Extrapapillary retinal hemangioblastomas greater than 4.5 mm in diameter pose a difficult challenge, with decreasing rates of success and increasing risks of treatment with increasing tumor size. Careful individualized assessment is essential before selecting an intervention in this high-risk setting.
Treatment Approach — Partial Overview
There is no single consensus strategy for this size range. Management options include ablative approaches to the scleral surface, radiotherapeutic techniques, and vitreoretinal surgical procedures — each carrying distinct risk-benefit profiles that guide selection. For tumors at elevated risk of significant post-treatment exudation, additional perioperative measures may be incorporated into the plan.
The full protocol — including specific indications, procedural sequencing, and perioperative management details — is available via the link below.
Treatment Goals
- A scar without any vestige of the retinal hemangioblastoma at the site of retinectomy (following surgical excision)
- Complete resolution of exudation
- Feeding and draining vessels reduced to ghost vessels
References
DOI: 10.1097/IAE.0000000000002572
- Extrapapillary RH greater than 4.5 mm in diameter pose a difficult challenge, with decreasing rates of success and increasing risks of treatment with increasing tumor size.
- Some have found that cryotherapy can sometimes be effective for lesions this size, in cases where it can be used with sufficiently low risk, but there is concern about the degree of exudation and vitreous contracture that can occur after treatment.
- Some of us consider brachytherapy for these large, high-risk tumors, while others typically offer vitrectomy with endocryotherapy or with excision of the tumor.
- Excision of an RH requires attention to intraocular hemostasis, which can include treatment of the lesion with endolaser photocoagulation, followed by diathermy to feeding vessels under high intraocular pressure prior to excision, or ligation of feeder vessels with intraocular suture prior to excision.
- Retinopexy is applied to the region of retinectomy, with use of gas or oil tamponade.
- Five years after vitrectomy with tumor excision and epiretinal membrane peeling, a scar without any vestige of the retinal hemangioblastoma is present at the site of retinectomy, exudation has completely resolved, and the feeding/draining vessels are reduced to ghost vessels.
View source ↗